Ultrasound Elasticity Imaging of Venous Thrombi

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

254 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-12-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see if the investigators can use ultrasound imaging to determine the type of clots in patients to help better manage their care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Venous Thrombus Investigation With Contrast Enhanced Ultrasound Imaging

NCT00677846

Deep Venous Thrombosis

UNKNOWN

Shear-Wave Elastography in Deep Vein Thrombosis

NCT06025591

Deep Vein Thrombosis

UNKNOWN

A New Technique to Diagnose Acute and Chronic Deep Vein Thrombosis

NCT02809638

Deep Vein Thrombosis Compression Ultrasound Elastography +1 more

COMPLETED

Location of Lower Extremity Deep Vein Thrombosis by Emergency Physicians Using Portable Compression Ultrasonography

NCT02262494

Deep Vein Thrombosis

TERMINATED NA

Study of Elastographic Properties of the Clot by Technical SWIRE (Shear Wave Induced Resonance Elastography)

NCT02859532

Deep Vein Thrombosis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Deep vein thrombosis (DVT) is a blood clot and is a common illness that can result in pain and death if not recognized and treated well. Death can occur when the venous clots break off and form pulmonary emboli (PE), which can block the arteries of the lungs. DVT and PE most often complicate the course of sick patients but may also affect healthy persons. DVT can also be a chronic disease. In those instances in which DVT and PE develop, in addition to the death risk, hospitalization is drawn out and healthcare costs are increased. Therefore, the purpose of this study is to see if we can use ultrasound imaging to determine the type of clots in patients to help better manage their care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Ultrasound imaging of Acute DVT (deep vein thrombosis)

Group Type EXPERIMENTAL

Ultrasound

Intervention Type PROCEDURE

Ultrasound imaging of Acute DVT

2

Ultrasound imaging of Chronic DVT (deep vein thrombosis)

Group Type EXPERIMENTAL

Ultrasound

Intervention Type PROCEDURE

Ultrasound imaging of Chronic DVT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

Ultrasound imaging of Acute DVT

Intervention Type PROCEDURE

Ultrasound

Ultrasound imaging of Chronic DVT

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female subjects who have a diagnosis of chronic DVT that is at least 2 weeks old and are free from an acute DVT on top of your chronic DVT.
* Male and female patients who have been diagnosed with an acute blood clot by the Diagnostic Vascular Lab and w/symptoms occurring within the previous 2 weeks.
* Patients under the age of 18 who give assent (permission) and whose parents give consent.
* Adult patients who give consent.